Sacroiliitis Treatment Market Research Report – Forecast to 2027

Global Sacroiliitis Treatment Market: Information by Type (Medications, Joint Injections, Joint Fusion, Radiofrequency Denervation, and Electrical Stimulation) and by End Users (Hospitals, Clinics, and Others)—Global Forecast till 2027

ID: MRFR/HC/5127-HCR | | Region: Global | 85 Pages         

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Sacroiliitis Treatment Market, by Type

6.1 Introduction

6.2 Medication

6.2.1 Pain relievers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.1 Muscle relaxants

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.1 TNF inhibitors

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Joint injections

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Radiofrequency denervation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5 Electrical stimulation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6 Joint fusion

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Sacroiliitis Treatment Market, by End-Users

7.1 Introduction

7.2 Hospitals

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Ambulatory care

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Homecare

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.6 Diagnostic centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.7 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Sacroiliitis Treatment Market, by Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 US

8.2.1.2 Canada

8.2.2 South America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 Italy

8.3.1.4 Spain

8.3.1.5 UK

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia-Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 South Korea

8.4.6 Rest of Asia-Pacific

8.5 Middle East & Africa

8.5.1 Middle East

8.5.2 Africa

Chapter 9. Company Landscape

9.1 Introduction

9.2 Market Share Analysis

9.3 Key Development & Strategies

Chapter 10. Company Profiles

10.1 Pfizer

10.1.1 Company Overview

10.1.2 Type Overview

10.1.3 Financials Overview

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 Allergan

10.2.1 Company Overview

10.2.2 Type Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Ipsen Group

10.3.1 Company Overview

10.3.2 Type Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 Teva Pharmaceuticals

10.4.1 Company Overview

10.4.2 Technology/Business Segment Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 Novartis

10.5.1 Company Overview

10.5.2 Type Overview

10.5.3 Financial overview

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.6 Johnson & Johnson

10.6.1 Company Overview

10.6.2 Type Overview

10.6.3 Financial Overview

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.7 STEROID S.p.A.

10.7.1 Overview

10.7.2 Type Overview

10.7.3 Financial Overview

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.8 Sanofi

10.8.1 Overview

10.8.2 Type/ Technology Overview

10.8.3 Financials

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.9 Bioventus

10.9.1 Overview

10.9.2 Type Overview

10.9.3 Financials

10.9.4 Key Developments

10.9.5 SWOT Analysis

10.10 Salix Pharmaceuticals

10.10.1 Overview

10.10.2 Type Overview

10.10.3 Financials

10.10.4 Key Developments

10.10.5 SWOT Analysis

10.11 Zimmer Holdings, Inc.

10. 11.1 Overview

10. 11.2 Type Overview

10. 11.3 Financials

10. 11.4 Key Developments

10.111.5 SWOT Analysis

10.12 Smith & Nephew Plc

10.12.1 Overview

10.12.2 Type Overview

10.12.3 Financials

10.12.4 Key Developments

10.12.5 SWOT Analysis

Chapter 11 MRFR Conclusion

11.1 Key Findings

11.1.1 From CEO’s Viewpoint

11.1.2 Unmet Needs of the Market

11.2 Key Companies to Watch

11.3 Predictions for the Sacroiliitis Treatment Industry

Chapter 12. Appendix

LIST OF TABLES

Table 1 Global Sacroiliitis Treatment Market Synopsis, 2020-2027

Table 2 Global Sacroiliitis Treatment Market Estimates and Forecast, 2020-2027(USD Million)

Table 3 Global Sacroiliitis Treatment Market, by Region, 2020-2027(USD Million)

Table 4 Global Sacroiliitis Treatment Market, by Type, 2020-2027(USD Million)

Table 7 Global Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)

Table 8 North America: Sacroiliitis Treatment Market, by Type, 2020-2027(USD

Million)

Table 9 North America: Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)

Table 10 US: Sacroiliitis Treatment Market, by Type, 2020-2027(USD Million)

Table 15 US: Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)

Table 16 Canada: Sacroiliitis Treatment Market, by Type, 2020-2027(USD Million)

Table 17 Canada Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)

Table 20 South America: Sacroiliitis Treatment Market, by Type, 2020-2027(USD

Million)

Table 23 South America: Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)

Table 24 Europe: Sacroiliitis Treatment Market, by Type, 2020-2027(USD Million)

Table 27 Europe: Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)

Table 28 Western Europe: Sacroiliitis Treatment Market, by Type, 2020-2027(USD

Million)

Table 31 Western Europe: Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)

Table 32 Eastern Europe: Sacroiliitis Treatment Market, by Type, 2020-2027(USD

Million)

Table 35 Eastern Europe: Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)

Table 36 Asia-Pacific: Sacroiliitis Treatment Market, by Type, 2020-2027(USD

Million)

Table 37 Asia-Pacific: Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)

Table 40 Middle East & Africa: Sacroiliitis Treatment Market, by Type, 2020-2027

(USD Million)

Table 43 Middle East & Africa: Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)


LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Sacroiliitis Treatment Market

Figure 3 Segmentation Market Dynamics for Global Sacroiliitis Treatment Market

Figure 4 Global Sacroiliitis Treatment Market Share, by Type, 2020

Figure 5 Global Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)

Figure 6 Global Sacroiliitis Treatment Market Share, by Region, 2020

Figure 7 North America: Sacroiliitis Treatment Market Share, by Country, 2020

Figure 8 Europe: Sacroiliitis Treatment Market Share, by Country, 2020

Figure 9 Asia-Pacific: Sacroiliitis Treatment Market Share, by Country, 2020

Figure 10 Middle East & Africa: Sacroiliitis Treatment Market Share, by Country, 2020

Figure 11 Global Sacroiliitis Treatment Market: Company Share Analysis, 2020 (%)

Figure 12 Pfizer: Key Financials

Figure 13 Pfizer: Segmental Revenue

Figure 14 Pfizer: Geographical Revenue

Figure 15 Allergan: Key Financials

Figure 16 Allergan: Segmental Revenue

Figure 17 Allergan: Geographical Revenue

Figure 18 Ipsen Group: Key Financials

Figure 19 Ipsen Group: Segmental Revenue

Figure 20 Ipsen Group: Geographical Revenue

Figure 21 Teva Pharmaceuticals: Key Financials

Figure 22 Teva Pharmaceuticals: Segmental Revenue

Figure 23 Teva Pharmaceuticals: Geographical Revenue

Figure 24 Novartis: Key Financials

Figure 25 Novartis: Segmental Revenue

Figure 26 Novartis: Geographical Revenue

Figure 27 Johnson & Johnson: Key Financials

Figure 28 Johnson & Johnson: Segmental Revenue

Figure 29 Johnson & Johnson: Geographical Revenue

Figure 30 STEROID S.p.A.: Key Financials

Figure 31 STEROID S.p.A.: Segmental Revenue

Figure 32 STEROID S.p.A.: Geographical Revenue

Figure 33 Sanofi: Key Financials

Figure 34 Sanofi: Segmental Revenue

Figure 35 Sanofi: Geographical Revenue

Figure 36 Bioventus: Key Financials

Figure 37 Bioventus: Segmental Revenue

Figure 38 Bioventus: Geographical Revenue

Figure 39 Salix Pharmaceuticals: Key Financials

Figure 40 Salix Pharmaceuticals: Segmental Revenue

Figure 41 Salix Pharmaceuticals: Geographical Revenue

Figure 42 Zimmer Holdings Inc.: Key Financials

Figure 43 Zimmer Holdings Inc.: Segmental Revenue

Figure 44 Zimmer Holdings Inc.: Geographical Revenue

Figure 45 Smith & Nephew Plc.: Key Financials

Figure 46 Smith & Nephew Plc.: Segmental Revenue

Figure 47 Smith & Nephew Plc.: Geographical Revenue

Market Scenario


The global sacroiliitis treatment market is expected to register a significant growth during the forecast period (2018–2023).


The sacroiliac joint also known as SI joint is the joint situated between the sacrum and the ilium bones of the pelvis, which is coupled by strong ligaments. In case of human being, the sacrum supports the spine and is supported in turn by an ilium on each side. The sacroiliitis is an inflammation of either one or both of sacroiliac joint. Sacroiliitis causes pain in the buttocks or lower back and can extend down one or both legs. Prolonged standing or stair climbing can increase the pain.


Numerous technological innovations in the devices along with an expanding profile of joint disorders foster the growth of the market. Increasing incidences and prevalence of joint disorders, growing awareness among the population, increase in initiatives by government organizations and investment by private companies for research and development, rising elderly population all contributes to the growth of the sacroiliitis treatment market. Though currently available therapeutic options are effective at managing and preventing joint disease progression, the challenges of treating the joint diseases lie in the unpredictable responses of each patient, representing one of the biggest unmet needs in the global sacroiliitis treatment market.


Segmentation


The global sacroiliitis treatment market has been segmented on the basis of type and end users.


On the basis of type, the market has been classified as medications, joint injections, radiofrequency denervation, electrical stimulation, joint fusion. The medications are segmented into pain relievers, muscle relaxants, and TNF inhibitors.


On the basis of end users, the market has been classified as hospitals, clinics, ambulatory care, home care, diagnostic centers, and others.


On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.


The European sacroiliitis treatment market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The sacroiliitis treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The sacroiliitis treatment market in the Middle East and Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Sacroiliitis Treatment Market Share, by Region, 2017 (%)


Sacroiliitis Treatment Market Share


Source: MRFR Analysis


In the sacroiliitis treatment market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures. According to a 2014 study shared by the US National Library of Medicine, approximately 19 to 29% of adults in the US are suffering from lower back pain and sacroiliitis joints. Patients who deal with chronic lower back pain spend about twice as much money on health-related expenses each year.


The European market is expected to hold the second largest market share. The market growth in this region can be attributed to the increasing number of surgeries and the increasing demand for advanced treatment procedures are boosting the European market.


The Asia-Pacific market is expected to be the fastest growing segment in the near future because of the high rate of development in the healthcare industry, increasing prospects for the new marketer and rising government activity for the control of joint disorders. Factors such as a rise in research expenses, advancement of technology, the decline in human health, and the necessity for innovative and effective therapies boost the growth of the market in this region.


The market in the Middle East and Africa is expected to account for the smallest share of the global sacroiliitis treatment market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.


Key Players


Some of the key players in the global sacroiliitis treatment market are Pfizer, Allergan, Ipsen Group, Teva Pharmaceuticals, Novartis, Johnson & Johnson, STEROID S.p.A., Sanofi, Bioventus, Salix Pharmaceuticals, Zimmer Holdings, Inc., Smith & Nephew Plc, and others.


Global Sacroiliitis Treatment Market, by Type



  • Medication

  • Pain relievers

  • Muscle relaxants

  • TNF inhibitors

  • Joint Injections

  • Radiofrequency denervation

  • Electrical stimulation

  • Joint fusion


Global Sacroiliitis Treatment Market, by End-Users



  • Hospitals

  • Maternity and specialty clinics

  • Diagnostic centers

  • Others


Global Sacroiliitis Treatment Market, by Region


Americas


  • North America

  • US

  • Canada

  • South America


Europe


  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe


Asia-Pacific


  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific


Middle East & Africa


  • Middle East

  • Africa


Intended Audience



  • Manufacturers and distributors

  • Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)

  • Research institutes

  • Contract manufacturing organizations (CMOs)

  • Government associations

  • Market research and consulting firms

  • Venture capitalists and investors



Speak to Analyst Ask for Customization